BioSig Achieves First Commercial Sale of Three PURE EP Systems

Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence

BioSig Technologies, Inc., a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, announced the purchase of three PURE EP™ Systems by St. David’s HealthCare of Austin, Texas. St. David’s Medical Center, an HCA Healthcare owned hospital, has been recognized with a Malcolm Baldrige National quality award – the highest presidential honor for performance excellence.

“Our first commercial sale to St. David’s HealthCare is an important milestone as we proceed in expanding our installed base nationwide,” said Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc. “This installation cements our valued relationship with St. David’s and adds to the traction we are gaining in the electrophysiology (EP) market.

BioSig installed the first PURE EP™ System at St. David’s Medical Center in November 2019. Shortly thereafter, Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center conducted the first patient cases under the Company’s clinical study, “Novel Cardiac Signal Processing System for Electrophysiology Procedures (PURE EP 2.0 Study).”

To date, more than 410 patient procedures have been conducted with the PURE EP™ System across six different hospital sites in the United States, with over 200 procedures performed at TCAI.

About BioSig Technologies
BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (www.biosig.com).

The Company’s first product, PURE EPä System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.